OBJECTIVE: To assess self-reported human papillomavirus (HPV) DNA testing practices by
health care providers and clinics, including nonrecommended practices such as low-risk …

Background The human papillomavirus (HPV) test, administered alone without the
Papanicolaou (Pap) test, was recently recognized as a cervical cancer screening option in …

OBJECTIVE: To evaluate the association between physician and practice characteristics
and adherence to management guidelines to better understand the factors associated with …

In the United States, high‐risk human papillomavirus (HPV) testing is recommended for
women with atypical squamous cells of unknown significance (ASC‐US) cytology, and co …

OBJECTIVE: To assess the consistency between human papillomavirus (HPV) mRNA
testing in women with a history of previous HPV infections diagnosed by HPV DNA assay …

Objective: We investigated the potential impact of using the high-risk human papillomavirus
(HPV) test as a primary screening tool for the detection of cervical cancer and its precursor …

Background: Cervical cancer screening has shifted toward human papillomavirus (HPV)-
based testing, but uptake of primary HPV screening in the United States is unknown and …

Background Primary HPV testing (without the Pap test) has recently been recommended as
a cervical cancer screening option in the United States. US women's awareness and …

OBJECTIVE: To estimate the 5-year age group–specific test positives for Pap tests and
human papillomavirus (HPV) testing in a large, general screening population of women 30 …

In 2009, the Cytopathology Education and Technology Consortium issued a statement on
human papillomavirus (HPV) DNA test utilization that was published in multiple journals. 1 …